A New York court has found enough evidence to proceed with a defamation lawsuit filed by Grifols against short seller Gotham ...

A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company ...

Below, we take a look at Grifols (GRFS), which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate ...

Grifols (GRFS) secures a win in its defamation lawsuit against Gotham City Research in the U.S. Read more here.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Grifols offers compelling long-term upside, with potential returns exceeding 200% as the company recovers and grows earnings.

Some Topeka doughnut shops, and some businesses selling other products, are offering free or discounted doughnuts to ...

One stock to keep an eye on is Grifols (GRFS). GRFS is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. Another notable valuation metric for GRFS is its P/B ratio of 0.65.

The City of Bowling Green Parks and Recreation Department, in partnership with title sponsor B.G. Transit and supporting ...

Health Minister Khaled Abdel Ghaffar met on Sunday, June 1st, 2025, with Magdy Amin, Chairman of Grifols Egypt, to discuss expanding cooperation in haematology and the national plasma derivatives ...

MADRID, May 30 (Reuters) - A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company Grifols (GRLS.MC), opens new tab against short ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...